adMare Discovery Session Featuring Brian Bloom

Join us on November 16, 2023, for an adMare Discovery Session featuring Brian Bloom, the co-founder, CEO, and Chairman of Bloom Burton & Co. 

The goal of all investors, companies, and organizations is to achieve a monetizing event, such as the ability to raise capital, perform meaningful research and development, license or commercialize products, reach profitability, or execute a strategic transaction. Bloom Burton & Co. is a firm dedicated to accelerating returns in the healthcare sector for both investors and companies. The company consists of an experienced team of medical, scientific, industry, and capital markets professionals who perform a deep level of diligence, which, combined with a creative and entrepreneurial approach, assists clients in achieving the right monetization events. Bloom Burton and its affiliates provide capital raising, M&A advisory, equity research, business and scientific advisory, as well as company creation and incubation services.

Mr. Bloom will dive deep into the past year, dissecting the investment landscape, financing trends, and the ebb and flow of risk capital within the Canadian life sciences arena. His insights will unveil the challenges and pivotal moments facing the industry. He also will share upcoming trends the industry will see in 2024. Don’t miss this event; register today!

Click here to register

About Mr. Brian Bloom
Brian Bloom is a co-founder of Bloom Burton & Co. and serves as the firm’s Chairman and Chief Executive Officer. By forging unique relationships with international healthcare-specialized investors, Brian raises capital for healthcare companies while helping investors realize returns.

Brian serves on the Board of Directors of Satellos Bioscience and Appili Therapeutics. Brian was formerly the Chairman of the Board of Grey Wolf Animal Health and Triumvira Immunologics, a member of the Life Sciences Advisory Board at the National Research Council of Canada, the Dean’s Advisory Board at McMaster University, and on the Board of Directors of BIOTECanada, the Baycrest Foundation and Qing Bile Therapeutics.

Before co-founding Bloom Burton in 2008, Brian spent six years at an independent investment dealer in the healthcare and biotechnology institutional sales and equity research groups. Brian started his career at New York-based investment banking firms SCO Financial Group and Molecular Securities. Brian received an Honours Bachelor of Science in Biochemistry from McMaster University and subsequently studied at the Mount Sinai Graduate School for Biological Sciences of New York University, focusing on molecular endocrinology and biophysics.

Brian is the proud recipient of the McMaster University 2017 Distinguished Alumni Award in Science and the co-recipient of the 2023 Life Sciences Ontario Community Service Award. In 2023, Bloom Burton celebrated its 15-year anniversary with an Ecosystem Builder Award from BIOTECanada.